Click for best price
Age Related Macular Degeneration AMD Diabetic Retinopathy DR Drugs Market Size, Share 2022
Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.
This report contains market size and forecasts of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in global, including the following market information:
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs companies in 2021 (%)
The global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Macular Degeneration Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs include Novartis, Bayer Healthcare, Roche, Neurotech Pharmaceuticals, Regeneron Pharmaceuticals and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment Percentages, by Type, 2021 (%)
Macular Degeneration Drugs
Diabetic Retinopathy Drugs
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment Percentages, by Application, 2021 (%)
50-60 Years Old
60-70 Years Old
Others
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs revenues share in global market, 2021 (%)
Key companies Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
| Report Attributes |
Report Details |
| Report Title |
Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Overall Market Size
2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size: 2021 VS 2028
2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in Global Market
3.2 Top Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies Ranked by Revenue
3.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Companies
3.4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Companies
3.5 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Markets, 2021 & 2028
4.1.2 Macular Degeneration Drugs
4.1.3 Diabetic Retinopathy Drugs
4.2 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue & Forecasts
4.2.1 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2022
4.2.2 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2023-2028
4.2.3 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales & Forecasts
4.3.1 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2017-2022
4.3.2 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2023-2028
4.3.3 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2021 & 2028
5.1.2 50-60 Years Old
5.1.3 60-70 Years Old
5.1.4 Others
5.2 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue & Forecasts
5.2.1 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2022
5.2.2 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2023-2028
5.2.3 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales & Forecasts
5.3.1 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2017-2022
5.3.2 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2023-2028
5.3.3 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2021 & 2028
6.2 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue & Forecasts
6.2.1 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2022
6.2.2 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2023-2028
6.2.3 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales & Forecasts
6.3.1 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2017-2022
6.3.2 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2023-2028
6.3.3 By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2028
6.4.2 By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2017-2028
6.4.3 US Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.4.4 Canada Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.4.5 Mexico Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2017-2028
6.5.3 Germany Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.5.4 France Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.5.5 U.K. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.5.6 Italy Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.5.7 Russia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.5.9 Benelux Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2017-2028
6.6.3 China Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.6.4 Japan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.6.5 South Korea Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.6.7 India Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2028
6.7.2 By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2017-2028
6.7.3 Brazil Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.7.4 Argentina Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, 2017-2028
6.8.3 Turkey Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.8.4 Israel Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
6.8.6 UAE Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.1.4 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporate Summary
7.2.2 Bayer Healthcare Business Overview
7.2.3 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.2.4 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Bayer Healthcare Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.3.4 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Neurotech Pharmaceuticals
7.4.1 Neurotech Pharmaceuticals Corporate Summary
7.4.2 Neurotech Pharmaceuticals Business Overview
7.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Neurotech Pharmaceuticals Key News
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Corporate Summary
7.5.2 Regeneron Pharmaceuticals Business Overview
7.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Regeneron Pharmaceuticals Key News
7.6 Allergan
7.6.1 Allergan Corporate Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Major Product Offerings
7.6.4 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Allergan Key News
8 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity, Analysis
8.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity, 2017-2028
8.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Supply Chain Analysis
10.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Value Chain
10.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Upstream Market
10.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in Global Market
Table 2. Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Companies, (K MT), 2017-2022
Table 6. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
Table 9. List of Global Tier 1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2017-2022
Table 15. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2023-2028
Table 16. By Application ? Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2017-2022
Table 20. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2023-2028
Table 21. By Region ? Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2017-2022
Table 25. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), 2023-2028
Table 26. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2017-2022
Table 29. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2023-2028
Table 30. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2017-2022
Table 33. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2023-2028
Table 34. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2017-2022
Table 37. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2023-2028
Table 38. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2017-2022
Table 41. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, (K MT), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 48. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Bayer Healthcare Corporate Summary
Table 50. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 51. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 54. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Neurotech Pharmaceuticals Corporate Summary
Table 56. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 57. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Regeneron Pharmaceuticals Corporate Summary
Table 59. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 60. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Allergan Corporate Summary
Table 62. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offerings
Table 63. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 65. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production by Region, 2017-2022 (K MT)
Table 67. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production by Region, 2023-2028 (K MT)
Table 68. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Opportunities & Trends in Global Market
Table 69. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Drivers in Global Market
Table 70. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Restraints in Global Market
Table 71. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Raw Materials
Table 72. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Raw Materials Suppliers in Global Market
Table 73. Typical Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Downstream
Table 74. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Downstream Clients in Global Market
Table 75. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segment by Type
Figure 2. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segment by Application
Figure 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue in 2021
Figure 9. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
Figure 19. US Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
Figure 24. Germany Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
Figure 33. China Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Region, 2021 VS 2028
Figure 50. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Value Chain
Figure 51. Marketing Channels
